RankingsPricing
  1. US-listed companies
  2. DEXCOM INC
  3. Financials
  4. Depreciation & amortization

DEXCOM INCDXCM

Market cap
$25.8B
P/E ratio
SummaryFinancials
Period EndDepreciation & amortization (Million USD)YoY (%)
Dec 31, 2024218+17.04%
Dec 31, 2023186+19.31%
Dec 31, 2022156+52.84%
Dec 31, 2021102+52.01%
Dec 31, 202067+37.78%
Dec 31, 201949+67.35%
Dec 31, 201829+80.75%
Dec 31, 201716+7.33%
Dec 31, 201615+38.89%
Dec 31, 201511+28.57%
Dec 31, 20148+20.00%
Dec 31, 20137+6.06%
Dec 31, 20127+75.58%
Dec 31, 20114

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)